Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence.

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence.

Item
http://www.wikidata.org/entity/Q37662391
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients.Redirecting the focus of cancer immunotherapy to premalignant conditions.Human Tumor Antigens Yesterday, Today, and Tomorrow.A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.Immunotherapy of cancer: targeting cancer during active disease or during dormancy?Progress in Vaccine Therapies for Breast Cancer.Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models.Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.Immunotherapy in Breast Cancer: the New Frontier.Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
P2860

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence.

Item
http://www.wikidata.org/entity/Q37662391
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary analysis of a prospect ...... atients to prevent recurrence.
@en
Primary analysis of a prospect ...... atients to prevent recurrence.
@nl
type
label
Primary analysis of a prospect ...... atients to prevent recurrence.
@en
Primary analysis of a prospect ...... atients to prevent recurrence.
@nl
prefLabel
Primary analysis of a prospect ...... atients to prevent recurrence.
@en
Primary analysis of a prospect ...... atients to prevent recurrence.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Primary analysis of a prospect ...... atients to prevent recurrence.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932